Back to all bills
HR 6166119th CongressIn Committee
Lowering Drug Costs for American Families Act
Introduced: Nov 20, 2025
Sponsor: Rep. Pallone, Frank [D-NJ-6] (D-New Jersey)
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Lowering Drug Costs for American Families Act expands Medicare's drug price negotiation program, applies inflation rebates to commercial markets, and establishes out-of-pocket limits for prescription drugs under private insurance.
Key Points
- 1Expands the number of drugs subject to Medicare negotiation from 20 to 50 per year
- 2Extends the drug price negotiation program to include participants in group and individual health plans
- 3Requires consideration of average international market prices in negotiations
- 4Repeals certain changes made by Public Law 119-21 to the negotiation program
- 5Applies prescription drug inflation rebates to drugs in the commercial market
- 6Establishes out-of-pocket limits for prescription drugs under private health insurance
Impact Areas
Medicare beneficiariesPrivate health insurance enrolleesPharmaceutical manufacturersHealth insurance issuersEmployers offering group health plans
Generated by kwaipilot/kat-coder-pro:free on Dec 6, 2025